EMA ADVISES ON CREATING SUB-GROUPS FOR CLINICAL TRIALS
February 1st, 2014THE EUROPEAN Medicines Agency (EMA) has issued guidance for pharmacos wanting to devise clinical trials based on separate groups of the population. Its advice looks at how assessments can look at one gender; healthy or unhealthy patients; subjects of certain ages; or living in particular regions. The guidelines say how to document and plan for such trials. *http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500160523.pdf
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.